中国经济网北京8月21日讯博拓生物(688767.SH)昨日晚间发布实际控制人减持股份计划公告。因自身资 金需求，公司实际控制人于秀萍拟通过大宗交易或集中竞价方式减持合计不超过4,479,999股，即不超过 公司股份总数的3%。 其中，以集中竞价方式减持不超过1,493,333股，不超过公司股份总数的1%；以大宗交易方式减持不超 过2,986,666股，不超过公司股份总数的2%。减持期间为自减持计划公告之日起15个交易日后的3个月 内。减持期间如遇法律法规规定的窗口期，则停止减持股份。若在上述减持期间内，公司有送红股、转 增股本、增发新股等股份变动事项，对应的减持股份数量、价格将进行相应的调整。 | 股东名称 | 于秀萍 | | --- | --- | | 计划减持数量 | 不超过:4,479,999 股 | | 计划减持比例 | 不超过:3% | | 减持方式及对应减持数 | 集中竞价减持,不超过:1,493,333 股 | | 量 | 大宗交易减持,不超过:2,986,666 股 | | 减持期间 | 2025年9月12日~2025年12月11日 | | 拟减持股份来源 | IPO 前取得、因权益分派转增 ...

Core Viewpoint - A total of 22 A-share listed companies disclosed share reduction plans, with no companies announcing share increases on the same day [1] Group 1: Companies and Their Reduction Plans - Dongfang Ocean plans to reduce its holdings by no more than 3% [2] - Nanmin Group's two shareholders intend to reduce their holdings by no more than 3.63% [2] - Xinhai Optoelectronics' shareholders Gao Zhan and Zhou Xuan plan to reduce their shares [2] - Yiming Food's shareholders will collectively reduce their holdings by no more than 3% [2] - Yingshi Sheng's shareholders plan to reduce their holdings by no more than 2% [2] - Jereh's vice chairman Wang Jili plans to reduce no more than 723,000 shares [2] - Hengyu Xintong's shareholders intend to reduce their holdings by no more than 2% [2] - Ruoyuchen's shareholder Langjing's shareholding will drop below 2% [2] - Zhongchumei's shareholder Wang Jing plans to reduce no more than 1% [2] - Jiangbolong's five employee shareholding platforms plan to reduce no more than 1.31% [2] - Puyuan Information's actual controller and its concerted actors plan to reduce their holdings by no more than 2.9951% [2] - Botuo Biological's actual controller Yu Xiuping plans to reduce no more than 3% [2] - Sanbo Brain Science's shareholder TBP plans to reduce no more than 3% [2] - Yijiahe's Huatai Zhanxin Investment and Daofeng Investment plan to reduce no more than 2% [2] - Rongzhirixin's controlling shareholder and concerted parties plan to reduce no more than 3% [2] - Taijin Investment's shareholders plan to reduce no more than 3% [2] - Xidian New Energy's shareholder Changjiang Chen Dao plans to reduce no more than 2% [2] - Huoshan's two shareholders plan to reduce a total of 5.45% [2] - Dongfang Zhaoye's chairman Feng Liming plans to reduce no more than 131,500 shares [2] - Nanjing New Hundred plans to reduce no more than 6 million shares of repurchased stock [2] - Xagong's shareholder Xiamen Kouhang plans to reduce no more than 1% [2] - Jinhongshun's shareholder Gaode Investment plans to reduce no more than 3% [2]

Shareholder Reduction - Shareholders Gao Zhan and Zhou Xuan of Xinhau Optoelectronics plan to reduce their holdings by a total of no more than 1.0176 million shares [1] - Shareholders Xinyue Investment, Mingniu Investment, and Chengyue Investment of Yiming Food plan to reduce their holdings by a total of no more than 12.03 million shares [1] - The consistent action party of shareholders holding more than 5% of Yingshisheng plans to reduce their holdings by no more than 2% [1] - Chairman and General Manager Nie Weihua of Rongzhi Rixin plans to reduce his holdings by no more than 1.40% [1] - Major shareholder Wang Jing of Zhongchumei plans to reduce his holdings by no more than 1.76 million shares [1] - Shareholder Huatai Zhanzheng Investment of Yijiahe plans to reduce their holdings by no more than 4.0972 million shares [1] - Actual controller Yu Xiuping of Botuo Biological plans to reduce his holdings by no more than 3% [1] Other Financial Information - Electric Science Cybersecurity reported a net loss of 170 million yuan in the first half of the year [1] - Ziaotai reported a net loss of 125 million yuan in the first half of the year [1]

Performance Disclosure - Muyuan Foods reported a revenue of 76.463 billion yuan for the first half of 2025, representing a year-on-year increase of 34.46%, with a net profit attributable to shareholders of 10.53 billion yuan, up 1169.77% year-on-year [1] - Shanghai Petrochemical reported a revenue of 39.52 billion yuan for the first half of 2025, a year-on-year decrease of 9.2%, with a net loss attributable to shareholders of 462 million yuan, transitioning from profit to loss [2] - Fuhuan Microelectronics reported a revenue of 688 million yuan for the first half of 2025, a year-on-year decrease of 14.04%, with a net profit attributable to shareholders of approximately 23.02 million yuan, down 78.1% year-on-year [3] Shareholding Changes - Botao Bio announced that its actual controller, Yu Xiuping, plans to reduce holdings by no more than 3% of the company's total shares, equating to approximately 4.48 million shares [4] - Sanbo Brain Science announced that shareholder TBP 3Doctors (HK) Limited plans to reduce holdings by no more than approximately 609,000 shares, accounting for 3% of the total share capital after excluding shares in the repurchase account [5] - Xiangshan Co. announced that two shareholders, Zhao Yukun and Chen Bo, reduced their holdings by a total of 5.45% of the company's shares, equating to 7.1996 million shares, with the reduction plan completed [6] Risk Matters - ST Zhongdi announced that 23.77% of the shares held by its controlling shareholder, totaling 71.1448 million shares, will be publicly auctioned from September 24 to 25, 2025, due to debt disputes, which may lead to a change in company control if the auction is successful [7] - Kailong Co. announced that its subsidiaries were fined a total of 1.762 million yuan for reaching a fixed price monopoly agreement, which is expected to reduce the company's net profit by approximately 1.3962 million yuan [8] - Tiansheng New Materials reported that Baoding Weishai New Materials Technology Co., Ltd. filed an appeal involving an amount of 802 million yuan, seeking to overturn a previous court ruling [9]

Performance Disclosure - Muyuan Foods reported a revenue of 76.463 billion yuan for the first half of 2025, representing a year-on-year increase of 34.46%, with a net profit attributable to shareholders of 10.53 billion yuan, up 1169.77% year-on-year [1] - Shanghai Petrochemical reported a revenue of 39.52 billion yuan for the first half of 2025, a year-on-year decrease of 9.2%, with a net loss attributable to shareholders of 462 million yuan, transitioning from profit to loss [2] - Fuhuan Microelectronics reported a revenue of 688 million yuan for the first half of 2025, a year-on-year decrease of 14.04%, with a net profit attributable to shareholders of approximately 23.02 million yuan, down 78.1% year-on-year [3] Shareholding Changes - Botao Biological announced that its actual controller, Yu Xiuping, plans to reduce holdings by no more than 3% of the company's total shares, equating to approximately 4.48 million shares [4] - Sanbo Brain Science announced that shareholder TBP 3Doctors (HK) Limited plans to reduce holdings by no more than approximately 609,000 shares, representing 3% of the total share capital after excluding shares in the repurchase account [5] - Xiangshan Co. announced that two shareholders, Zhao Yukun and Chen Bo, reduced their holdings by a total of 5.45% of the company's shares, equating to 7.1996 million shares, with the reduction plan completed [6] Risk Matters - ST Zhongdi announced that 23.77% of the shares held by its controlling shareholder, totaling 71.1448 million shares, will be publicly auctioned from September 24 to 25, 2025, due to debt disputes, which may lead to a change in company control [7] - Kailong Co. announced that its subsidiaries were fined a total of 1.762 million yuan for reaching a fixed price monopoly agreement, which is expected to reduce the company's net profit by approximately 1.3962 million yuan [8] - Tiansheng New Materials reported that Baoding Weishai New Materials Technology Co., Ltd. filed an appeal involving an amount of 802 million yuan, seeking to overturn a previous court ruling [9]

公告显示，于秀萍持有公司股份2495.36万股，占公司股份总数的16.71%。 北京商报讯（记者 丁宁）8月20日晚间，博拓生物（688767）发布公告称，因自身资金需求，公司实际 控制人于秀萍拟通过大宗交易或集中竞价方式减持合计不超过约448股，即不超过公司股份总数的3%。 ...

格隆汇8月20日丨博拓生物(688767.SH)公布，因自身资金需求，实控人于秀萍女士拟通过大宗交易或集 中竞价方式减持合计不超过448万股，即不超过公司股份总数的3%。其中：以集中竞价方式减持不超过 149.33万股，不超过公司股份总数的1%；以大宗交易方式减持不超过298.67万股，不超过公司股份总数 的2%。减持期间为自本减持计划公告之日起15个交易日后的3个月内。减持期间如遇法律法规规定的窗 口期，则停止减持股份。 ...

格隆汇8月20日丨博拓生物(688767.SH)公布，因自身资金需求，实控人于秀萍女士拟通过大宗交易或集 中竞价方式减持合计不超过448万股，即不超过公司股份总数的3%。其中：以集中竞价方式减持不超过 149.33万股，不超过公司股份总数的1%；以大宗交易方式减持不超过298.67万股，不超过公司股份总数 的2%。减持期间为自本减持计划公告之日起15个交易日后的3个月内。减持期间如遇法律法规规定的窗 口期，则停止减持股份。 ...

证券代码：688767 证券简称：博拓生物 公告编号：2025-036 杭州博拓生物科技股份有限公司 实际控制人减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 股东持股的基本情况 截至本公告披露日，杭州博拓生物科技股份有限公司（以下简称"公司"） 实际控制人于秀萍女士持有公司股份 24,953,600 股，占公司股份总数的 16.71%。 上述股份均为公司首次公开发行前取得的股份、因权益分派转增的股份，均已上 市流通。 减持计划的主要内容 因自身资金需求，于秀萍女士拟通过大宗交易或集中竞价方式减持合计不超 过 4,479,999 股，即不超过公司股份总数的 3%。其中：以集中竞价方式减持不 超过 1,493,333 股，不超过公司股份总数的 1%；以大宗交易方式减持不超过 2,986,666 股，不超过公司股份总数的 2%。减持期间为自本减持计划公告之日起 15 个交易日后的 3 个月内。减持期间如遇法律法规规定的窗口期，则停止减持 股份。若在上述减持期间内，公司有送红股、转增 ...

每经AI快讯，博拓生物8月20日公告，实际控制人于秀萍因自身资金需求，拟通过大宗交易或集中竞价 方式减持合计不超过4479999股，即不超过公司股份总数的3%。减持期间为自本减持计划公告之日起15 个交易日后的3个月内。 ...